乳がんの治療支援としての人工知能:現在の展望
Stefan Lukac1, Florian Putz2, Giacomo De Micheli3
1Department of Obstetrics and Gynecology, University Hospital Ulm, Ulm, Germany.
Breast (Edinburgh, Scotland)
|August 29, 2025
まとめ
人工知能 (AI) は乳がん (BC) 管理,特に診断と放射線治療において有望である. しかし,手術や全身治療における AI アプリケーションはまだ開発中であり,その利点と限界を慎重に評価する必要があります.
科学分野:
- 腫瘍学
- 医療情報学
- 医療における人工知能
背景:
- 乳がん (BC) 管理に関するデータの量が増えるため,先進的なツールが必要になります.
- 人工知能 (AI) は大きなデータセットを統合し,BC治療の質を向上させる可能性を秘めています.
- 様々なBC管理領域におけるAIアプリケーションの臨床的準備は明確化が必要です.
研究 の 目的:
- 乳がん治療の様々な側面における AI の利用に関する現在のデータをレビューする.
- BC管理において,AIが臨床実施の準備ができている分野と,まだ開発中の分野を特定する.
主な方法:
- 乳がんにおけるAI応用に関する既存の文献の記述レビュー.
- 診断,外科療法,放射線療法,全身治療/サポート療法におけるAIの役割に焦点を当てます.
主要な成果:
- AIは マンモグラフィのスクリーニング,手術前相談,放射線腫瘍学で成功していることが示されています.
- 術内,術後,全身性/サポート性乳がん治療におけるAIの応用は,現在開発段階にある.
- 人工知能の精度は異なるため 利点と欠点を慎重に検討する必要があります
結論:
- AIは乳がん患者のケアを 改善する大きな可能性を秘めています
- 乳がん管理におけるAIの臨床実施は進んでおり,異なる治療方法によって準備が異なる.
- バランスの取れたアプローチが必要で AIの利点と 現在の限界と正確さを 比較する必要があります
関連する概念動画
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


